Przebieg procesu zapalnego w narządach immunologicznie uprzywilejowanych

• Autorzy: Madej J.A. , Madej J. P. , Kandefer-Gola M.

Warianty tytułu

EN

Inflammatory process in immune-privileged organs

• Języki publikacji: PL

Abstrakty

EN

Organs in which inflammation goes by different rules through protecting them against damage are called immunologically privileged. These include the central nervous system, the front chamber of the eye (excluding the cornea), the liver, the kernel, the pregnant uterus, hamster cheek pouches and hyaline cartilage. The brain immunological privilege is due to fact that it has no lymphatic vessels and contains a small number of T-lymphocytes and macrophages, while a blood-brain barrier is present. In the brain, there is a long-term graft survival of allo-and xenografts, such as the adrenal medulla tissue or fetal tissue allografts. The anterior chamber of the eye is also an immunologically privileged area, which is often a convenient place for grafts of experimental tumors in animals. Inside the testes tolerance of autoantigens present in the germ cells is attained, which is maintained by the presence of incomplete barriers limiting access to reproductive cell antigens of immune cells and antibodies. In other parts of the body such a response to an antigen is not found, which makes these organs very interesting from the point of view of pathogenesis and immunity.

Słowa kluczowe

PL

narzady uprzywilejowane immunologicznie; stany zapalne; przeszczepy allogeniczne; limfocyty; bariera krew-mozg; przebieg procesu zapalnego

• Wydawca: -
• Czasopismo: Medycyna Weterynaryjna
• Rocznik: 2013
• Tom: 69
• Numer: 06
• Opis fizyczny: s.333-340,rys.,tab.,bibliogr.

Twórcy

autor

Madej J.A.

• Zakład Patomorfologii i Weterynarii Sądowej, Katedra Patologii, Wydział Medycyny Weterynaryjnej, Uniwersytet Przyrodniczy we Wrocławiu, ul.Norwida 31, 50-345 Wrocław

autor

Madej J. P.

• Zakład Histologii i Embriologii, Katedra Biostruktury i Fizjologii Zwierząt, Wydział Medycyny Weterynaryjnej, Uniwersytet Przyrodniczy we Wrocławiu, ul.Norwida 25/27, 50-375 Wrocław

autor

Kandefer-Gola M.

• Zakład Patomorfologii i Weterynarii Sądowej, Katedra Patologii, Wydział Medycyny Weterynaryjnej, Uniwersytet Przyrodniczy we Wrocławiu, ul.Norwida 31, 50-345 Wrocław

Bibliografia

• 1. Abbott N. J.: Inflammatory mediators and modulation of blood-brain barrier permeability. Cell. Mol. Neurobiol. 2000, 20, 131-147.
• 2. Apte R. S., Sinha D., Mayhew E., Wistow G. J., Niederkorn J. Y.: Cutting edge: role of macrophage migration inhibitory factor in inhibiting NK cell activity and preserving immune privilege. J. Immunol. 1998, 160, 5693-5696.
• 3. Barker C. F., Billingham R. E.: Immunologically privileged sites. Adv. Immunol. 1977, 25, 1-54.
• 4. Bechmann I., Priller J., Kovac A., Böntert M., Wehner T., Klett F. F., Bohsung J., Stuschke M., Dirnagl U., Nitsch R.: Immune surveillance of mouse brain perivascular spaces by blood-borne macrophages. Eur. J. Neurosci. 2001, 14, 1651-1658.
• 5. Carson M. J., Doose J. M., Melchior B., Schmid C. D., Ploix C. C.: CNS immune privilege: hiding in plain sight. Immunol. Rev. 2006, 213, 48-65.
• 6. Caspi R.: Autoimmunity in the immune privileged eye: pathogenic and regulatory T cells. Immunol. Res. 2008, 42, 41-50.
• 7. Charian L., Hlatky R., Robertson C. S.: Nitric oxide in traumatic brain injury. Brain Path. 2004, 14, 195-201.
• 8. Chen H., Zhang S. M., Hernán M. A., Schwarzschild M. A., Willett W. C., Colditz G. A., Speizer F. E., Ascherio A.: Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease. Arch Neurol. 2003, 60, 1059-1064.
• 9. Colton C. A.: Heterogeneity of microglial activation in the innate immune response in the brain. J. Neuroimmune Pharmacol. 2009, 4, 399-418.
• 10. Crane I. J., Liversidge J.: Mechanisms of leukocyte migration across the blood - retina barrier. Semin. Immunopathol. 2008, 30, 165-177.
• 11. D'Orazio T. J., Niederkorn J. Y.: A novel role of TGF-beta and IL-10 in the induction of immune privilege. J. Immunol. 1998, 160, 2089-2098.
• 12. Duvernoy H. M., Risold P. Y.: The circumventricular organs: an atlas of comparativy anatomy and vascularization. Brain Res. Rev. 2007, 56, 119-147.
• 13. Engelhardt B., Laschinger M., Schulz M., Samulowitz U., Vestweber D., Hoch G.: The development of experimental autoimmune encephalomyelitis in the mouse requires alpha4-integrin but not alpha4beta7-integrin. J. Clin. Invest. 1998, 102, 2096-2105.
• 14. Fournel S., Aguerre-Girr M., Huc X., Lenfant F., Alam A., Toubert A., Bensussan A., Le Bouteiller P.: Cutting edge: soluble HLA-G1 triggers CD95/CD95 ligand-mediated apoptosis in activated CD8⁺ cells by interacting with CD8. J. Immunol. 2000, 164, 6100-6104.
• 15. Gołąb J., Jakóbisiak M., Lasek W. (red.): Immunologia. Wyd. Naukowe PWN, Warszawa 2005.
• 16. Grenn D. R., Ferguson T. A.: The role of Fas ligand in immune privilege. Nat. Rev. Mol. Cell Biol. 2001, 2, 917-924.
• 17. Griffith T. S., Brunner T., Flechter S. M.: FAS ligand-induced apoptosis as a mechanism of immune privilege. Science 1995, 270, 189-192.
• 18. Guazzone V. A., Jacobo P., Theas M. S., Lustig L.: Cytokines and chemokines in testicular inflammation: A brief review. Microsc. Res. Tech. 2009, 72, 620-628.
• 19. Hickey W. F.: Basic principles of immunological surveillance of the normal central nervous system. Glia 2000, 36, 118-124.
• 20. Hori J.: Mechanisms of immune privilege in the anterior segment of the eye: what we learn from corneal transplantation. J. Ocul. Biol. Dis. Inform. 2008, 1, 94-100.
• 21. Hori J., Vega J. L., Masli S. H.: Review of ocular immune privilege in the year 2010: modifying the immune privilege of the eye. Ocular Immun. Inflammation 2010, 18, 325-333.
• 22. Kumar A., Stoica B. A., Sabirzhanov B., Burns M. P., Faden A. I., Loane D. J.: Traumatic brain injury in aged animals increases lesion size and chronically alters microglial/macrophage classical and alternative activation states. Neurobiol Aging. 2012, pii: S0197-4580(12)00590-8. doi: 10.1016/j.neurobiolaging. 2012.11.013. [Epub ahead of print]
• 23. Le W., Rowe D., Xie W., Ortiz I., He Y., Appel S. H.: Microglial activation and dopaminergic cell injury: an in vitro model relevant to Parkinson's disease. J. Neurosci. 2001, 21, 8447-8455.
• 24. Lee H. O., Herndon J. M., Barreiro R., Griffith T. S., Ferguson T. A.: TRAIL: a mechanism of tumor surveillance in an immune privileged site. J. Immunol. 2002, 169, 4739-4744.
• 25. Lee N., Llano M., Carretero M., Ishitani A., Navarro F., Lo´Pez-Botet M., Geraghty D. E.: HLA-E is a major ligand for the natural killer inhibitory receptor CD94/ NKG2A. Proc. natl. Acad. Sci. USA 1998, 95, 5199-5204.
• 26. Mackiewicz S. (red.): Immunologia. PZWL, Warszawa 1991.
• 27. Medawar P. B.: Immunity to homologous grafted skin. III. The fate of skin homografts transplanted to the brain, to subcutaneous tissue, and to the chamber of the eye. Br. J. Exp. Pathol. 1948, 29, 58-69.
• 28. Matyszak M. K., Perry V. H.: The potential role of dendritic cells in immunemediated inflammatory diseases in the central nervous system. Neuroscience 1996, 74, 599-608.
• 29. McCarron R. M., Wang L., Racke M. K., McFarlin D. E., Spatz M.: Cytokineregulated adhesion between encephalitogenic T lymphocytes and cerebrovascular endothelial cells. J. Neuroimmunol. 1993, 43, 23-30.
• 30. McGeer E., Yasojima K., McGeer P. L.: Inflammation in the pathogenesis of Parkinson's disease. BCMJ, 2001, 43, 138-141.
• 31. McMahon E. J., Bailey S. L., Castenada C. V., Waldner H., Miller S. D.: Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis. Nat. Med. 2005, 11, 335-339.
• 32. McMenamin P. G., Wealthall R. J., Deverall M., Cooper S. J., Griffin B.: Macrophages and dendritic cells in the rat meninges and choroid plexus: three-dimensional localisation by environmental scanning electron microscopy and confocal microscopy. Cell Tissue Res. 2003, 313, 259-269.
• 33. Miller J. F. A. P., Basten A.: Mechanisms of tolerance to self. Curr. Opin. Immunol. 1996, 8, 815-821.
• 34. Mrass P., Weninger W.: Immune cell migration as a means to control immune privilege: les sons from the CNS and tumors. Immun. Rev. 2006, 213, 195-212.
• 35. Nasr I. W., Wang Y., Gao G., Deng S., Diggs L., Rothstein D. M., Tellides G., Lakkis F. G., Dai Z.: Testicular immune privilege promotes transplantation tolerance by altering the balance between memory and regulatory T cells. J. Immunol. 2005, 174, 6161-6168.
• 36. Neumann J., Sauerzweig S., Rönicke R., Gunzer F., Dinkel K., Ullrich O., Gunzer M., Reymann K. G.: Microglia cells protect neurons by direct engulfment of invading neutrophil granulocytes: a new mechanism of CNS immune privilege. J. Neurosci. 2008, 4, 5965-5975.
• 37. Niederkorn J. Y.: See no evil, hear no evil, do no evil: the lessons of immune privilage. Nature Immun. 2006, 7, 354-359.
• 38. Niederkorn J. Y., Stein-Streilein J.: History and physiology of immune privilege. Ocular Immun. Inflammation 2010, 18, 19-23.
• 39. Pachter J. S., de Vries H. E., Fabry Z.: The blood-brain barier and its role in immune privilege in the central nervous system. J. Neuropathol. Exp. Neurol. 2003, 62, 593-604.
• 40. Petty M. A., Lo E. H.: Junctional complexes of the blood-brain barrier: permeability changes in neuroinflammation. Prog. Neurobiol. 2002, 68, 311-323.
• 41. Rouas-Freiss N., Gonçalves R. M., Menier C., Dausset J., Carosella E. D.: Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis. Proc. natl Acad. Sci. USA 1997, 94, 11520-11525.
• 42. Saban D. R., Bock F., Chauhan S. K., Masli S., Dana R.: Thrombospondin-1 derived from APCs regulates their capacity for allosensitization. J. Immunol. 2010, 15, 4691-4697.
• 43. Sonoda K. H., Stein-Streilein J.: NKT cell-derived IL-10 is essentials for the differentiation of antygen-specific T regulatory cells in systemic tolerance. J. Immunol. 2001, 166, 42-50.
• 44. Streit W. J.: Microglia as neuroprotective, immunocomplement cells of the CNS. Glia 2002, 40, 133-139.
• 45. Taylor H. R., Johnson S. L., Schachter J., Cadwell H. D., Prendergast R. A.: Pathogenesis of trachoma: the stimulus for inflammation. J. Immunol. 1987, 138, 3023-3027.
• 46. Tsai C. Y., Chow N. H., Ho T. S., Lei H. Y.: Intracerebral injection of myelin basic protein (MBP) induces inflammation in brain and causes paraplegia in MBP-sensitized B6 mice. Clin. Exp. Immunol. 1997, 109, 127-133.
• 47. Ubogu E. E., Cossoy M. B., Ransohoff R. N.: The expression and function of chemokines involved in CNS inflammation. Trends Pharmacol. Sci. 2006, 27, 48-55.
• 48. Weiss J. M., Downie S. A., Lyman W. D., Berman J. W.: Astrocyte-derived monocyte-chemoattractant protein-1 directs the transmigration of leukocytes across a model of the human blood-brain barrier. J. Immunol. 1997, 161, 6896-6903.
• 49. Willbanks G. A., Streilein J. W.: Studies in the induction of anterior chamberassociated immune deviation (ACAID). 1 Evidence that an antygen-specific, ACAID-inducing, cell-associated signac exists in the peripheral blood. J. Immunol. 1991, 146, 2610-267.
• 50. Wu H., Wang H., Xiong W., Chen S., Tang H., Han D.: Expression patterns and functions of Toll-like receptors in mouse Sertoli cells. Endocrinology 2008, 149, 4402-4412.
• 51. Yamada T., McGeer P. L., McGeer E. G.: Lewy bodies in Parkinson's disease are recognized by antibodies to complement proteins. Acta Neuropathol. 1992, 84, 100-104.